Table 2.
Minimum inhibitory concentration (MIC) and Susceptibility of bacterial strains to amoxicillin, ciprofloxacin, or amikacin
| Antibiotics | Strains | MIC (µg/mL) | Antibiotic Susceptibility (S/I/R) |
|---|---|---|---|
| Amoxicillin | S. aureus (Patient 1) | 8 | I |
| S. aureus (Patient 2) | 2 | S | |
| S. aureus (Patient 3) | 16 | R | |
| Ciprofloxacin | P. aeruginosa (Patient 1) | 16 | R |
| P. aeruginosa (Patient 2) | 8 | R | |
| P. aeruginosa (Patient 3) | 1 | I | |
| Amikacin | S. aureus (Patient 1) | 2 | S |
| S. aureus (Patient 2) | 4 | S | |
| S. aureus (Patient 3) | 2 | S | |
| P. aeruginosa (Patient 1) | 1 | S | |
| P. aeruginosa (Patient 2) | 1 | S | |
| P. aeruginosa (Patient 3) | 4 | S |
S susceptible; Iintermediate; Rresistant. Interpretations are based on EUCAST and CLSI clinical breakpoints